Neurasthenia (DBCOND0006191)
Identifiers
- Synonyms
- Other specified nonpsychotic mental disorders / Other malaise / Bodily distress disorder (disorder) / Neurasthenic neurosis / Nervous debility / Dysthymic disorder / Dysthymia / Dysthymia (disorder) / Depression, unspecified / Depressive illness / Depressive neurosis / Depressive disorder (disorder) / Depressive disorder / Depressive disorders / Weakness / Asthenia / Asthenia (finding)
Associated Data
- Indicated Drugs and Targets
Drug Description Targets Flupentixol A thioxanthene neuroleptic used to treat schizophrenia and depression.- Alpha-1A adrenergic receptortarget
- D(2) dopamine receptortarget
- D(1A) dopamine receptortarget
- Aromatic-L-amino-acid decarboxylaseenzyme
- 5-hydroxytryptamine receptor 2Atarget
- ATP-dependent translocase ABCB1transporter
- Muscarinic acetylcholine receptor M1target
- Liver carboxylesterase 1enzyme
- D(3) dopamine receptortarget
- D(4) dopamine receptortarget
- 5-hydroxytryptamine receptor 2Ctarget
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT05586789 A Study of the Efficacy and Safety of Ranquilon Tablets in Patients With Anxiety in Neurasthenia and Adjustment Disorders treatment 3 completed NCT02141568 Effectiveness of Mind-Body Interventions for Frequent Attendees Suffering From Medically Unexplained Symptoms (MUS) No drug interventions treatment Not Available terminated